News

ZYMOX® Receives Notable Recognition for Pet Healthcare Products

ZYMOX® Receives Notable Recognition for Pet Healthcare Products

ZYMOX® Products Shine in Editor's Select Awards

The acclaimed enzymatic pet healthcare brand, ZYMOX, has recently achieved remarkable acclaim by receiving top honors in four categories: Bird, Dog, Reptile, and Small Animal. This recognition emphasizes the brand's unwavering commitment to enhancing pet well-being through its innovative products.

A Legacy of Quality and Innovation

Pet King Brands, the founder of ZYMOX, has a longstanding reputation for excellence in creating veterinarian-recommended enzymatic products. The company has consistently introduced groundbreaking solutions that cater to the health needs of pets worldwide. The recent acknowledgment by Pet Age magazine speaks volumes about the company's dedication to providing high-quality pet care solutions.

Highlighted Products

Among the honored products are the ZYMOX Avian Care line, featuring both the ZYMOX Avian Care Topical Solution and the ZYMOX Avian Care Topical Spray, specifically designed for birds. Other celebrated offerings include ZYMOX Enzymatic Ear Solution with 0.5% Hydrocortisone and the ZYLAFEN® Topical Solution. Additionally, the ZYMOX Small Animal & Exotic line showcases exceptional products like the ZYMOX Small Animal & Exotic Topical Solution and the ZYMOX Small Animal & Exotic Topical Spray.

Commitment to Pet Health

Debra Decker, Director of Marketing at Pet King Brands, shared her enthusiasm regarding the recognition: "We're honored to have six of our ZYMOX products recognized in four of the Editor's Select categories. The LP3 Enzyme System – combined with our dedication to manufacturing each ZYMOX product in the USA – truly sets our offerings apart. This acknowledgment from Pet Age's 2026 Editor's Select Awards reinforces the exceptional science and care behind everything we create."

Importance of the Editor's Select Program

The Editor's Select program by Pet Age aims to recognize products that exemplify high standards in quality and effectiveness for improving pet health. The selection process identifies innovations that are poised to enhance the well-being of pets, ensuring that only the best products make it to the final list.

Explore More

The complete list of honorees for the Pet Age "2026 Editor's Select" program is available online, showcasing an impressive lineup of recognized pet care products. For those interested in learning more about ZYMOX and its offerings, detailed product information can be found on the official website.

Contact Information and About Pet King Brands

For media inquiries or more information about ZYMOX products, please contact K. Sutherland PR at (775) 360-6101. Pet King Brands has been a leader in enzyme-based, veterinarian-approved pet healthcare since 1998. The company, led by President and Founder Pamela Bosco, prides itself on its innovative LP3 Enzyme System that revolutionizes care for animals' ears, skin, and dental health.

Frequently Asked Questions

What is ZYMOX recognized for by Pet Age?

ZYMOX was awarded for its high-quality products in four specific categories—Bird, Dog, Reptile, and Small Animal.

What types of products does ZYMOX offer?

ZYMOX offers a variety of products including ear solutions, topical care solutions, and dental care products specifically designed for pets.

Who leads Pet King Brands?

Pet King Brands is led by Pamela Bosco, who is the President and Founder of the company.

How does the LP3 Enzyme System benefit pets?

The LP3 Enzyme System works gently to clean and maintain the health of pets' ears, skin, and mouths, minimizing the need for harsh chemicals.

Where can I find more information about ZYMOX?

More information about ZYMOX products can be found on their official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sky Labs' CART Monitor Advances BP Monitoring Tech

Updated Category News Views 3

Cuffless BP Monitoring: Changing the Game for AF and HF Ever thought a finger ring could revolutionize blood pressure monitoring? Well, welcome to the future—Sky Labs' ring-type CART monitor has just rocked the scene at the ESC Congress 2026 in Munich. This isn't sci-fi, folks; it's where health tech meets reality, and it's shaking the very foundations of how we manage...

Continue Reading
EQT Wraps Up Share Buyback with 4.3M Shares Repurchased

Updated Category News Views 1

EQT's Bold Buyback: Crunching the Numbers Alright, let's peel back the curtain on EQT's latest maneuver—finishing up their share buyback program, all neat and tidy for 2026. They nailed down 707,203 of their own shares just in the first week of September, part of a grand total of 4,368,899 snatched up in the entire effort. That's a whopping SEK 1.448 billion invested in...

Continue Reading
Hyosung Targets U.S. AI Power Market with Advanced SST

Updated Category News Views 1

Hyosung's Game-Changing Move in the AI Power Sector Guess what? The AI era's heating up, and it's dragging the power sector along for a wild ride. Hyosung Chairman Hyun-Joon Cho peered into that future and decided it's all-in time for the U.S. power market. With AI and data centers cranking up power demands like never before, those rickety old wires need an upgrade fast....

Continue Reading
Stem Cell Market Set for Major Gains to 2031

Updated Category News Views 1

Stem Cells: The Next Frontier or Hype? Folks, stem cells are no longer just a sci-fi concept tucked away in lab coats. This sector's set to boom from USD 18.9 billion in 2026 to a whopping USD 32.57 billion by 2031. Yeah, you heard it right, a solid 11.5% compound annual growth rate. Now, whether you're an investor or just keeping your finger on the biotech pulse, there's...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 5

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Consumer365 Highlights Happy Head's Personalized Hair Solutions

Updated Category News Views 1

Tailored Hair Loss Solutions by Happy Head Imagine trying to fit a square peg in a round hole. That's what one-size-fits-all approaches often feel like in the world of hair loss treatments. Happy Head, recognized by Consumer365, takes that notion and turns it on its head, offering personalized minoxidil formulations for women. The key word here is personalized. More Than...

Continue Reading
Beazer Homes Sale Scrutinized for Shareholder Impact

Updated Category News Views 1

Spotlight on Beazer Homes' Proposed Sale Here's a real head-scratcher for folks in the stock trenches: Beazer Homes USA, Inc. (NYSE: BZH) finds itself under the microscope with Halper Sadeh LLC stirring the pot. You can't make this up—just another day in the world of investor rights and looming litigation. Questions Arise Over Shareholder Gains Halper Sadeh LLC, that...

Continue Reading
Lida Group Expands Global Modular Construction Services

Updated Category News Views 5

Modular Construction's Expanding Footprint Behold Lida Group—a titan in the world of modular construction—taking ambitious strides into the global arena, reaching from the sand dunes of Saudi Arabia to the bustling corridors of the United Nations. If you haven't been paying attention, now's the time to get your head in the game. Their expansion isn't just about...

Continue Reading
CABP Market Sees Potential in New Treatments Rising

Updated Category News Views 2

Rising Threats and New Solutions in CABP Market Listen up, folks. The community-acquired bacterial pneumonia (CABP) market is set to swell. And why is that? Well, it's got everything to do with a growing disease burden, aging populations, and complications from comorbid conditions. But here's the kicker: antimicrobial resistance is climbing like a cat up a tree, and that...

Continue Reading
UST Grabs Italdesign: Driving Future Mobility with AI

Updated Category News Views 3

UST's Strategic Move Into Automotive's Future Wake up and smell the coffee, because UST is shaking up the automotive scene. They've just pulled off a major play by grabbing a majority stake in Italdesign. If that doesn't scream the next leap forward for the auto world, I don't know what does. UST isn't just buying a company; it's marrying Italdesign's legendary design...

Continue Reading

Top 5 Most Recently Viewed Articles

Precision BioSciences Expands Leadership Team for Growth

Updated Category News Views 134

Precision BioSciences Expands Leadership Team for Growth Precision BioSciences, Inc. (Nasdaq: DTIL), a pioneering clinical-stage gene editing company, has made significant changes to its senior leadership team as it aims to advance its in vivo gene editing programs, including the promising PBGENE-HBV project currently in Phase 1 clinical studies. Strategic Leadership...

Continue Reading
Understanding Qualcomm's Short Interest Trends and Implications

Updated Category News Views 201

Qualcomm Short Interest Overview Qualcomm (QCOM) has recently reported a significant decrease in its short percent of float, which has dropped by 9.4% since the last report. Currently, there are 21.02 million shares sold short, representing 2.12% of the company's total regular shares available for trading. Based on recent trading volumes, it would take approximately 2.25...

Continue Reading
Simply Good Foods Company Delivers Strong Q1 Performance

Updated Category News Views 117

Simply Good Foods Company Shows Positive Growth Simply Good Foods Company (NASDAQ: SMPL), a leader in the nutrition snack industry, has reported impressive financial results for its fiscal first quarter, ending November 30, 2024. This period marks a significant year-over-year improvement in sales and profitability. Financial Highlights of Q1 2025 Impressive Sales and...

Continue Reading
Denmark's Bold Move to Safeguard Personal Identity Rights Against AI

Updated Category News Views 272

Denmark's Progressive Stance on Deepfake Technology Denmark is taking a significant step in the realm of digital privacy by updating its copyright laws to safeguard individual rights against deepfake technology. This innovative move allows citizens to have legal ownership of their own faces, voices, and bodies. In a world where AI-generated imitations are becoming...

Continue Reading
Spotlight Biographees: Celebrating Remarkable Achievements

Updated Category News Views 284

Spotlight Biographees: Celebrating Remarkable Achievements The Spotlight Series highlights the impressive resumes and career accomplishments of hand-selected professionals. Marquis Who's Who (MWW), the leading biographical publisher globally, proudly acknowledges a diverse group of professionals recognized in the Spotlight Series for their outstanding contributions. This...

Continue Reading